ATE495187T1 - Dalda-analoge und ihre verwendung - Google Patents
Dalda-analoge und ihre verwendungInfo
- Publication number
- ATE495187T1 ATE495187T1 AT00917550T AT00917550T ATE495187T1 AT E495187 T1 ATE495187 T1 AT E495187T1 AT 00917550 T AT00917550 T AT 00917550T AT 00917550 T AT00917550 T AT 00917550T AT E495187 T1 ATE495187 T1 AT E495187T1
- Authority
- AT
- Austria
- Prior art keywords
- dalda
- analogues
- management
- pain
- compounds
- Prior art date
Links
- UEVAHGMTRWGMTB-JBXUNAHCSA-N (2s)-6-amino-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Chemical class C([C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 UEVAHGMTRWGMTB-JBXUNAHCSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treating Waste Gases (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9900961A SE9900961D0 (sv) | 1999-03-16 | 1999-03-16 | Novel compounds |
PCT/SE2000/000462 WO2000055189A1 (en) | 1999-03-16 | 2000-03-08 | Dalda analogs and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE495187T1 true ATE495187T1 (de) | 2011-01-15 |
Family
ID=20414882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00917550T ATE495187T1 (de) | 1999-03-16 | 2000-03-08 | Dalda-analoge und ihre verwendung |
Country Status (8)
Country | Link |
---|---|
US (2) | US6703483B1 (de) |
EP (1) | EP1163263B1 (de) |
AT (1) | ATE495187T1 (de) |
AU (1) | AU3850600A (de) |
CA (1) | CA2361364C (de) |
DE (1) | DE60045508D1 (de) |
SE (1) | SE9900961D0 (de) |
WO (1) | WO2000055189A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541021B1 (en) * | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
US7074803B2 (en) * | 2001-03-02 | 2006-07-11 | Durect Corporation | Opioid formulations |
WO2002005748A2 (en) | 2000-07-18 | 2002-01-24 | Cornell Research Foundation, Inc. | Medicinal uses of mu-opioid receptor agonists |
US20040102476A1 (en) * | 2002-11-25 | 2004-05-27 | Chan Tai Wah | High concentration formulations of opioids and opioid derivatives |
CN102784383B (zh) * | 2003-02-04 | 2014-09-17 | 科内尔研究基金会 | 用于防止线粒体通透性改变的方法 |
KR101161823B1 (ko) * | 2003-05-01 | 2012-07-03 | 코넬 리서치 화운데이션,인크. | 세포로 분자를 전달하는 방법 및 이것을 위한 캐리어 복합체 |
CA2971931C (en) | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
US20050282756A1 (en) * | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
KR20140106761A (ko) * | 2005-09-16 | 2014-09-03 | 코넬 리서치 화운데이션,인크. | Cd36 발현을 감소시키는 방법 |
US8093207B2 (en) * | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
EP3441079A1 (de) | 2008-02-07 | 2019-02-13 | Cornell University | Verfahren zur vorbeugung oder behandlung von insulinresistenz |
EP2262520B1 (de) | 2008-02-26 | 2017-05-03 | Cornell University | Zusammensetzungen zur prävention und behandlung von nierenschädigung |
EP3563862B1 (de) | 2009-03-20 | 2021-05-05 | The General Hospital Corporation d/b/a Massachusetts General Hospital | D-arg-2'6'-dimethyltyrosin-lys-phe-nh2 zur verhinderung von sekundären komplikationen von brandverletzungen |
CN107412724A (zh) * | 2009-08-12 | 2017-12-01 | 康奈尔大学 | 预防或治疗代谢综合症的方法 |
CN102625709A (zh) | 2009-08-24 | 2012-08-01 | 康肽德生物医药技术有限公司 | 用于预防或治疗眼科病症的方法和组合物 |
US20110082084A1 (en) * | 2009-10-05 | 2011-04-07 | Szeto Hazel H | Methods for the prevention or treatment of heart failure |
EP3375449A1 (de) * | 2010-03-15 | 2018-09-19 | Stealth Peptides International, Inc. | Kombinationstherapien mit cyclosporin und aromatischen kationischen peptiden |
US20110245182A1 (en) | 2010-04-06 | 2011-10-06 | Perricone Nicholas V | Topical Uses of Szeto-Schiller Peptides |
US20110245183A1 (en) | 2010-04-06 | 2011-10-06 | Perricone Nicholas V | Topical Uses of Szeto-Schiller Peptides |
US20120083452A1 (en) | 2010-09-30 | 2012-04-05 | Perricone Nicholas V | Topical Anesthetic Uses of Szeto-Schiller Peptides |
JP2017523956A (ja) | 2014-06-25 | 2017-08-24 | フラマ ソシエタ ペル アチオニFlamma S.P.A. | D−アルギニル−2,6−ジメチル−l−チロシル−l−リシル−l−フェニルアラニンアミドの調製方法 |
PL3160985T3 (pl) | 2014-06-30 | 2021-12-27 | Flamma S.P.A. | Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu |
CA2978905A1 (en) * | 2015-03-06 | 2016-09-15 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
WO2018187400A1 (en) | 2017-04-05 | 2018-10-11 | Stealth Biotherapeutics Corp. | Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 |
US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
KR102666922B1 (ko) | 2020-09-09 | 2024-05-20 | 소셜 프로핏 네트워크 | 미토콘드리아에 비오틴의 전달을 위한 방법 및 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312899A (en) * | 1988-06-30 | 1994-05-17 | Biochem Pharma, Inc. | Dermorphin analogs |
US5602100A (en) * | 1988-06-30 | 1997-02-11 | Astra Ab | Dermorphin analogs having pharmacological activity |
IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
US5788307A (en) * | 1996-08-23 | 1998-08-04 | Gilbert; Louis A. | Pickup body protection apparatus |
US5885958A (en) * | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
-
1999
- 1999-03-16 SE SE9900961A patent/SE9900961D0/xx unknown
-
2000
- 2000-03-08 CA CA2361364A patent/CA2361364C/en not_active Expired - Lifetime
- 2000-03-08 AU AU38506/00A patent/AU3850600A/en not_active Abandoned
- 2000-03-08 WO PCT/SE2000/000462 patent/WO2000055189A1/en active Application Filing
- 2000-03-08 AT AT00917550T patent/ATE495187T1/de not_active IP Right Cessation
- 2000-03-08 EP EP00917550A patent/EP1163263B1/de not_active Expired - Lifetime
- 2000-03-08 US US09/590,165 patent/US6703483B1/en not_active Expired - Lifetime
- 2000-03-08 DE DE60045508T patent/DE60045508D1/de not_active Expired - Lifetime
-
2004
- 2004-02-25 US US10/785,155 patent/US20040176305A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1163263B1 (de) | 2011-01-12 |
SE9900961D0 (sv) | 1999-03-16 |
CA2361364A1 (en) | 2000-09-21 |
US20040176305A1 (en) | 2004-09-09 |
AU3850600A (en) | 2000-10-04 |
CA2361364C (en) | 2011-02-15 |
DE60045508D1 (de) | 2011-02-24 |
EP1163263A1 (de) | 2001-12-19 |
US6703483B1 (en) | 2004-03-09 |
WO2000055189A1 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE495187T1 (de) | Dalda-analoge und ihre verwendung | |
SE9504661D0 (sv) | New compounds | |
SE0101387D0 (sv) | Novel compounds | |
WO2004060882A8 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
NO20065904L (no) | Terapeutiske forbindelser | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
SE9802208D0 (sv) | Novel compounds | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
SE0104250D0 (sv) | Heterocyclic compounds | |
SE9802206D0 (sv) | Novel compounds | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0203070D0 (en) | Novel compounds | |
SE0203303D0 (sv) | Novel Compounds | |
TW200504030A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0203300D0 (sv) | Novel Compounds | |
SE9802209D0 (sv) | Novel compounds | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
SE9504662D0 (sv) | New compounds | |
UY27587A1 (es) | Heterociclos terapéuticos | |
ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |